A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 900, Issue , 2012, Pages 89-93

  Chen, Wei ^a,b   Fan Havard, Patty ^b,c   Yee, Lisa D ^b   Cao, Yu ^b   Stoner, Gary D ^d   Chan, Kenneth K ^b,e,f   Liu, Zhongfa ^b,e  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Curcumin; Curcumin O glucuronide; Liquid chromatography tandem mass spectrometry; Pharmacokinetics

Indexed keywords

ANALYTIC METHOD; CLINICAL SETTINGS; CURCUMIN; CURCUMIN-O-GLUCURONIDE; HERBAL MEDICINES; HUMAN DISEASE; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; LINEAR RANGE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; ORAL INGESTION; SPECTROMETRIC METHODS;

BIOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACOKINETICS; POSITIVE IONS;

PLASMA (HUMAN);

CURCUMIN; CURCUMIN O GLUCURONIDE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PH; PLASMA; PRIORITY JOURNAL; ROOM TEMPERATURE; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; CURCUMIN; DRUG STABILITY; GLUCURONIDES; HUMANS; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84862755170     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.05.026     Document Type: Article

References (10)

1. Song Z., Feng R., Sun M., Guo C., Gao Y., Li L., Zhai G. J. Colloid. Interface Sci. 2011, 354:116-123.
2. Mukerjee A., Vishwanatha J.K. Anticancer Res. 2009, 29:3867-3875.
3. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Cancer Lett. 2008, 267:133-164.
4. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Mol. Pharm. 2007, 4:807-818.
5. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Clin. Cancer Res. 2008, 14:4491-4499.
6. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1411-1417.
7. Asai A., Miyazawa T. Life Sci. 2000, 67:2785-2793.
8. Pan M.H., Huang T.M., Lin J.K. Drug Metab. Dispos. 1999, 27:486-494.
9. Vijaya Saradhi U.V., Ling Y., Wang J., Chiu M., Schwartz E.B., Fuchs J.R., Chan K.K., Liu Z. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878:3045-3051.
10. Lao C.D., Ruffin M.T.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., Boggs M.E., Crowell J., Rock C.L., Brenner D.E. BMC Complement. Altern. Med. 2006, 6:10.